Secretome Therapeutics to Present Phase 1 Clinical Data Evaluating STM-01 in Heart Failure with Preserved Ejection Fraction at HFSA Annual Scientific Meeting

Secretome Therapeutics, a clinical-stage biotechnology company developing novel therapies derived from neonatal cardiac ...